Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat life-threatening multidrug-resistant (MDR) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA Hot Corp. News Hot FDA News Trading Halts

Tetraphase Pharmaceuticals (TTPH) PT Lowered to $6 at Stifel; Path Forward Complicated, But Still ThereFebruary 14, 2018 6:28 AM Tetraphase Announces Top-Line Results from IGNITE3 Phase 3 Clinical Trial of Eravacycline in Complicated Urinary Tract Infections (cUTI)February 13, 2018 4:01 PM Tetraphase Pharma (TTPH) Halted, News PendingFebruary 13, 2018 4:00 PM